OKYO (OKYO Pharma) Total Equity: $-3.42 Mil (As of Sep. 2025)


OKYO OKYO Pharma Ltd OKYO
23 GF Score
Price $1.75
! 3 Warning Signs
View Full Analysis

What is OKYO Pharma Total Equity?

OKYO Pharma OKYO +8.70% 23 Total Equity is $-3.42 Mil as of Sep. 2025. GuruFocus rates OKYO with a GF Score™ of 23/100. The stock has 3 warning signs investors should review.

OKYO Pharma's total equity for the quarter that ended in Sep. 2025 was $-3.42 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

OKYO Pharma Total Equity Historical Data

* Premium members only.

The historical data trend for OKYO Pharma's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OKYO Pharma Total Equity Chart

OKYO Pharma Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.32 2.95 -2.05 -5.88 -5.55

OKYO Pharma Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -5.88 -7.23 -5.55 -3.42
OKYO
23GF Score
OKYO Pharma Ltd OKYO
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OKYO Pharma Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

OKYO Pharma's Total Equity for the fiscal year that ended in Mar. 2025 is calculated as

Total Equity=Total Assets(Q: Mar. 2025 )-Total Liabilities(Q: Mar. 2025 )
=3.677-9.227
=-5.55

OKYO Pharma's Total Equity for the quarter that ended in Sep. 2025 is calculated as

Total Equity=Total Assets(Q: Sep. 2025 )-Total Liabilities(Q: Sep. 2025 )
=4.644-8.059
=-3.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $-3.42 Mil mean?
OKYO Pharma (OKYO) has a Total Equity of $-3.42 Mil as of Sep. 2025. The total amount of equity as record on a company's balance sheet. View historical data for OKYO Pharma and its competitors.
Is OKYO Pharma's Total Equity too high?
OKYO Pharma's current Total Equity is $-3.42 Mil. Overall, OKYO Pharma has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does OKYO Pharma's Total Equity compare to ENTX and HRTX?
OKYO Pharma's Total Equity of $-3.42 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for OKYO Pharma and its competitors. OKYO Pharma's current Total Equity is $-3.42 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OKYO Pharma stock overvalued right now?
OKYO Pharma (OKYO) has a current Total Equity of $-3.42 Mil. The current Total Equity is $-3.42 Mil. OKYO Pharma's overall GF Score™ is 23/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For OKYO Pharma (OKYO), the current Total Equity is $-3.42 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OKYO Pharma Business Description

Address 14/15 Conduit Street, Floor 4, London, GBR, W1S 2XJ
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
23GF Score

Get the complete analysis for OKYO

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.75
Price